Medicare Enrolled

Dr. Khalid Abulaban, M.D.

Q: Does Dr. Abulaban receive payments from pharmaceutical companies?

Yes. Dr. Abulaban received a total of $1,023 from 15 companies across 45 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.

Q: What does Data Coverage mean?

Data Coverage (currently High for Dr. Abulaban) measures how much public federal data is available about a provider. It is not a quality rating. A Very High or High level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A Low or Moderate level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative.

Pediatric Nephrology · Grand Rapids, MI

35 MICHIGAN ST NE, Grand Rapids, MI 49503

6162672700

Registered in NPPES since 2008

NPI: 1033379458 verify on NPPES ↗

High

DATA COVERAGE

Data in 3 of 4 federal sources

Measures public federal data availability — not provider quality

Informational, not a quality rating. This page presents federal public records about Dr. Abulaban from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →

Are you Dr. Abulaban? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Abulaban

Dr. Khalid Abulaban is a pediatric nephrology specialist in Grand Rapids, MI, with 18 years of NPI registration.

Between the years covered by Open Payments, Dr. Abulaban received a total of $1,023 from 15 pharmaceutical and/or device companies across 45 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Abulaban is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years of NPI registration $1,023 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗

$1,023

Total received (2018-2024)

Avg $146/year across 7 years

Top 0% in MI for pediatric nephrology

A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.

Companies

Payment records

Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024

$124

2023

$119

2022

$337

2021

$12

2020

$62

2019

$151

2018

$218

Payments by company (2024)

Novartis Pharmaceuticals Corporation

$36

ABBVIE INC.

$35

SOBI, INC

$34

Kiniksa Pharmaceuticals International, plc

$20

Top 3 companies account for 84.3% of 2024 payments

All-time payments by company (2018-2024) ›

Novartis Pharmaceuticals Corporation

$247

Amgen Inc.

$217

GlaxoSmithKline, LLC.

$151

Silvergate Pharmaceuticals, Inc.

$82

SOBI, INC

$68

PFIZER INC.

$59

ABBVIE INC.

$35

E.R. Squibb & Sons, L.L.C.

$30

Sandoz Inc.

$25

AbbVie, Inc.

$24

QIAGEN SCIENCES LLC

$20

Kiniksa Pharmaceuticals International, plc

$20

Alexion Pharmaceuticals, Inc.

$19

Ultragenyx Pharmaceutical Inc.

$14

BioMarin Pharmaceutical Inc.

$14

Top 3 companies account for 60.1% of all-time payments

Associated products mentioned in payments ›

Arcalyst · BENLYSTA · COSENTYX · Cryvista · Enbrel · HYRIMOZ · Humira · ILARIS · KINERET · MDx Quantiferon · ORENCIA · RINVOQ · SOLIRIS · SYNAGIS · Vimizim · XELJANZ · Xatmep

Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Looking for a pediatric nephrology specialist in Grand Rapids?
Compare pediatric nephrologists in the Grand Rapids area by procedure volume, costs, and industry payment transparency.

Browse pediatric nephrologists nearby

Geographic Context

Pediatric nephrologists in nearby ZIP areas

County median income

$80,390

Nearest hospital to ZIP centroid (approximate)

SPECTRUM HEALTH
0.0 mi

Data Sources

Provider Registry	✓ NPPES	NPPES snapshot; verify current record
Medicare Enrollment	✓ PECOS	PECOS snapshot
Practice Data	— No data	N/A
Industry Payments	✓ Open Payments	CY 2024
Disciplinary History	— Not included	N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Abulaban is a pediatric nephrology specialist, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Abulaban receive payments from pharmaceutical companies?

Yes. Dr. Abulaban received a total of $1,023 from 15 companies across 45 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.

What does Data Coverage mean?

Data Coverage (currently High for Dr. Abulaban) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →

Is this data up to date?

Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city

Pediatric Nephrologists in Grand Rapids

Browse pediatric nephrologists in Grand Rapids ranked by procedure volume and transparency data.

Highest volume

Top Pediatric Nephrologists in MI

Pediatric nephrologists ranked by total Medicare services performed statewide.

Industry payments

Pharma Payments to Pediatric Nephrologists in MI

Which MI pediatric nephrologists receive the most from drug and device companies.

By company

Novartis Pharmaceuticals Corporation Payments to Doctors

See all physicians who received payments from Novartis Pharmaceuticals Corporation.

By company

Amgen Inc. Payments to Doctors

See all physicians who received payments from Amgen Inc.

By company

GlaxoSmithKline, LLC. Payments to Doctors

See all physicians who received payments from GlaxoSmithKline, LLC.

About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology